Imaging of NASH

Akihiro Tanimoto, Kengo Tomita

Research output: Contribution to journalArticle

Abstract

Nonalcoholic steatohepatitis (NASH) is the most serious form of nonalcoholic fatty liver disease (NAFLD). Although imaging studies identify hepatic steatosis when the amount of fat in the liver is significant, differences between NASH and nonprogressive NAFLD were not apparent with any imaging modalities. Ultimately a liver biopsy is needed to diagnose NASH. Because NASH is a progressive fibrotic disease, patients with NASH and cirrhosis may progress to hepatocellular carcinoma(HCC). Regular screening based on tumor markers and imaging modalities is needed to detect HCC, in patients with NASH and cirrhosis.

Original languageEnglish
Pages (from-to)1127-1132
Number of pages6
JournalNippon rinsho. Japanese journal of clinical medicine.
Volume64
Issue number6
Publication statusPublished - 2006 Jun

Fingerprint

Hepatocellular Carcinoma
Liver
Fibrosis
Non-alcoholic Fatty Liver Disease
Tumor Biomarkers
Fats
Biopsy

Cite this

Imaging of NASH. / Tanimoto, Akihiro; Tomita, Kengo.

In: Nippon rinsho. Japanese journal of clinical medicine., Vol. 64, No. 6, 06.2006, p. 1127-1132.

Research output: Contribution to journalArticle

Tanimoto, A & Tomita, K 2006, 'Imaging of NASH', Nippon rinsho. Japanese journal of clinical medicine., vol. 64, no. 6, pp. 1127-1132.
Tanimoto, Akihiro ; Tomita, Kengo. / Imaging of NASH. In: Nippon rinsho. Japanese journal of clinical medicine. 2006 ; Vol. 64, No. 6. pp. 1127-1132.
@article{25cefcf3402e4511998a3ad688a6c6d5,
title = "Imaging of NASH",
abstract = "Nonalcoholic steatohepatitis (NASH) is the most serious form of nonalcoholic fatty liver disease (NAFLD). Although imaging studies identify hepatic steatosis when the amount of fat in the liver is significant, differences between NASH and nonprogressive NAFLD were not apparent with any imaging modalities. Ultimately a liver biopsy is needed to diagnose NASH. Because NASH is a progressive fibrotic disease, patients with NASH and cirrhosis may progress to hepatocellular carcinoma(HCC). Regular screening based on tumor markers and imaging modalities is needed to detect HCC, in patients with NASH and cirrhosis.",
author = "Akihiro Tanimoto and Kengo Tomita",
year = "2006",
month = "6",
language = "English",
volume = "64",
pages = "1127--1132",
journal = "Nihon rinsho. Japanese journal of clinical medicine",
issn = "0047-1852",
publisher = "Nipponrinsho Co., Inc.",
number = "6",

}

TY - JOUR

T1 - Imaging of NASH

AU - Tanimoto, Akihiro

AU - Tomita, Kengo

PY - 2006/6

Y1 - 2006/6

N2 - Nonalcoholic steatohepatitis (NASH) is the most serious form of nonalcoholic fatty liver disease (NAFLD). Although imaging studies identify hepatic steatosis when the amount of fat in the liver is significant, differences between NASH and nonprogressive NAFLD were not apparent with any imaging modalities. Ultimately a liver biopsy is needed to diagnose NASH. Because NASH is a progressive fibrotic disease, patients with NASH and cirrhosis may progress to hepatocellular carcinoma(HCC). Regular screening based on tumor markers and imaging modalities is needed to detect HCC, in patients with NASH and cirrhosis.

AB - Nonalcoholic steatohepatitis (NASH) is the most serious form of nonalcoholic fatty liver disease (NAFLD). Although imaging studies identify hepatic steatosis when the amount of fat in the liver is significant, differences between NASH and nonprogressive NAFLD were not apparent with any imaging modalities. Ultimately a liver biopsy is needed to diagnose NASH. Because NASH is a progressive fibrotic disease, patients with NASH and cirrhosis may progress to hepatocellular carcinoma(HCC). Regular screening based on tumor markers and imaging modalities is needed to detect HCC, in patients with NASH and cirrhosis.

UR - http://www.scopus.com/inward/record.url?scp=33746557599&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33746557599&partnerID=8YFLogxK

M3 - Article

C2 - 16768120

AN - SCOPUS:33746557599

VL - 64

SP - 1127

EP - 1132

JO - Nihon rinsho. Japanese journal of clinical medicine

JF - Nihon rinsho. Japanese journal of clinical medicine

SN - 0047-1852

IS - 6

ER -